These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36669714)
1. The role of EZH2 as a potential therapeutic target in retinoblastoma. Zhao Y; Cheng Y; Qu Y Exp Eye Res; 2023 Feb; 227():109389. PubMed ID: 36669714 [TBL] [Abstract][Full Text] [Related]
2. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Khan M; Walters LL; Li Q; Thomas DG; Miller JM; Zhang Q; Sciallis AP; Liu Y; Dlouhy BJ; Fort PE; Archer SM; Demirci H; Dou Y; Rao RC Lab Invest; 2015 Nov; 95(11):1278-90. PubMed ID: 26280220 [TBL] [Abstract][Full Text] [Related]
3. EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target. Lin Z; Tang L; Chen S; Zhang W; Lin J; Gao H; Zhang P Ophthalmic Res; 2023; 66(1):1014-1019. PubMed ID: 37311441 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6. Liu Y; Liang G; Wang H; Liu Z Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502 [TBL] [Abstract][Full Text] [Related]
5. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. Guihurt Santiago J; Burgos-Tirado N; Lafontaine DD; Mendoza Sierra JC; Camacho RH; Vecchini Rodríguez CM; Morales-Tirado V; Flores-Otero J BMC Cancer; 2021 Jan; 21(1):53. PubMed ID: 33430814 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo. Sun QX; Wang RR; Liu N; Liu C Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398 [TBL] [Abstract][Full Text] [Related]
7. miR-29a inhibits human retinoblastoma progression by targeting STAT3. Liu S; Zhang X; Hu C; Wang Y; Xu C Oncol Rep; 2018 Feb; 39(2):739-746. PubMed ID: 29251322 [TBL] [Abstract][Full Text] [Related]
8. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway. Fu C; Wang S; Jin L; Zhang M; Li M Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919 [No Abstract] [Full Text] [Related]
9. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152 [TBL] [Abstract][Full Text] [Related]
10. microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a. Lyu X; Wang L; Lu J; Zhang H; Wang L Oncol Rep; 2019 May; 41(5):3137-3147. PubMed ID: 30896857 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways. Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380 [TBL] [Abstract][Full Text] [Related]
12. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Huang B; Huang M; Li Q Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685 [TBL] [Abstract][Full Text] [Related]
13. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p. Wu XZ; Cui HP; Lv HJ; Feng L Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143 [TBL] [Abstract][Full Text] [Related]
16. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465 [No Abstract] [Full Text] [Related]
17. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978 [TBL] [Abstract][Full Text] [Related]
18. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression. Lu X; Tu H; Tang D; Huang X; Sun F Curr Eye Res; 2022 Mar; 47(3):418-425. PubMed ID: 34547965 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target. Cao J; Pontes KC; Heijkants RC; Brouwer NJ; Groenewoud A; Jordanova ES; Marinkovic M; van Duinen S; Teunisse AF; Verdijk RM; Snaar-Jagalska E; Jochemsen AG; Jager MJ J Pathol; 2018 Aug; 245(4):433-444. PubMed ID: 29732557 [TBL] [Abstract][Full Text] [Related]
20. Sinomenine Can Inhibit the Growth and Invasion Ability of Retinoblastoma Cell through Regulating PI3K/AKT Signaling Pathway. Zheng Q; Zhu Q; Li C; Hao S; Li J; Yu X; Qi D; Pan Y Biol Pharm Bull; 2020 Oct; 43(10):1551-1555. PubMed ID: 32759601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]